Patrick Machado
CIK 1311210 · View on SEC EDGAR ↗
First SEC filing: June 3, 2026 · Latest: June 3, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2018 | ABUS | P | 664,000 | $100.00 | $66,400,000 | 1,164,000 Indirect | +132.80% | Acquired | -95.1% (price as of 2026-08-20) |
| Oct. 16, 2017 | ABUS | P | 500,000 | $100.00 | $50,000,000 | 500,000 Indirect | — | Acquired | -95.1% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 30, 2026 | ALMS | Stock Option (Right to Buy) | Common Stock (15,528) | $28.14 | June 29, 2036 | 15,528 | Acquired |
| June 11, 2026 | RCUS | Stock Option (Right to Buy) | Stock Option (Rights to Buy) (16,900) | $23.30 | June 10, 2036 | 16,900 | Acquired |
| June 3, 2026 | XENE | Restricted Share Units | Common Shares (1,593) | $0.00 | — | 1,593 | Acquired |
| June 3, 2026 | XENE | Share Option (Right to Buy) | Common Shares (10,507) | $53.46 | June 2, 2036 | 10,507 | Acquired |
| June 1, 2026 | XENE | Restricted Share Units | Common Shares (2,645) | — | — | 2,645 | Disposed |
| June 5, 2024 | XENE | Stock Option (Right to Buy) | Common Shares (15,542) | $38.16 | June 4, 2034 | 15,542 | Acquired |
| June 15, 2023 | RCUS | Stock Option (Right to Buy) | Common Stock (19,500) | $19.60 | June 14, 2033 | 19,500 | Acquired |
| June 2, 2023 | XENE | Stock Option (Right to Buy) | Common Shares (18,475) | $38.96 | June 1, 2033 | 18,475 | Acquired |
| June 28, 2022 | XENE | Stock Option (Right to Buy) | Common Shares (18,000) | $30.11 | June 27, 2032 | 18,000 | Acquired |
| June 14, 2022 | RCUS | Stock Option (Right to Buy) | Common Stock (16,800) | $20.62 | June 13, 2032 | 16,800 | Acquired |
| June 3, 2021 | RCUS | Stock Option (Right to Buy) | Common Stock (14,100) | $24.79 | June 2, 2031 | 14,100 | Acquired |
| June 3, 2021 | XENE | Stock Option (Right to Buy) | Common Shares (10,000) | $18.56 | June 2, 2031 | 10,000 | Acquired |
| Nov. 5, 2020 | XENE | Stock Option (Right to Buy) | Common Shares (20,000) | $11.85 | Nov. 4, 2030 | 20,000 | Acquired |
| June 4, 2020 | RCUS | Stock Option (Right to Buy) | Common Stock (14,000) | $30.05 | June 3, 2030 | 14,000 | Acquired |
| Dec. 10, 2019 | RCUS | Stock Option (right to buy) | Common Stock (50,000) | $8.55 | Dec. 9, 2029 | 50,000 | Acquired |
| Jan. 2, 2019 | SCYX | Stock Option (right to buy) | Common Stock (22,500) | $0.54 | Jan. 1, 2029 | 22,500 | Acquired |
| Jan. 12, 2018 | ABUS | Series A Participating Convertible Preferred Shares | Common shares, no par value | — | Oct. 16, 2021 | 664,000 | Acquired |
| Jan. 2, 2018 | SCYX | Stock Option (right to buy) | Common Stock (19,989) | $2.28 | Jan. 1, 2028 | 19,989 | Acquired |
| Oct. 16, 2017 | ABUS | Series A Participating Convertible Preferred Shares | Common shares, no par value | — | Oct. 16, 2021 | 500,000 | Acquired |
| June 20, 2017 | RCKTW | Stock Options (Right to Buy) | Common Stock (45,000) | $1.80 | June 19, 2027 | 45,000 | Acquired |
| Aug. 17, 2016 | RCKTW | Stock Options (Right to Buy) | Common Stock (24,000) | $6.91 | Aug. 17, 2026 | 24,000 | Acquired |
| Sept. 24, 2015 | SCYX | Stock Option (right to buy) | Common Stock (11,700) | $6.89 | Sept. 23, 2025 | 11,700 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (170,167) | 170,167 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (109,732) | 109,732 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (109,732) | 109,732 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (109,732) | 109,732 | Direct |
| Oct. 1, 2021 | ROIV | Stock Option (Right to Buy)→ Common Shares (109,732) | 109,732 | Direct |
| Nov. 5, 2020 | XENE | No securities are beneficially owned | 0 | Indirect |
| Nov. 5, 2020 | XENE | No securities are beneficially owned→ N/A [F1] | — | Direct |
| Oct. 19, 2016 | ABUS | Common Shares, no par value | 16,013,540 | Indirect |